Physician

Nancy Y Olson, MD

According to 2025 Medicare claims, Nancy Olson, MD (NPI: 1265543466) practices allergy/immunology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Johnson, KS. This provider's primary affiliated billing organization is ARCKC LLC (NPI: 1861756041; TIN: 45-5348175) and primary practice location at 66212-5701.

Olson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 58,058 HCPCS/CPT codes, and received $473,052 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,117 prescription claims across 162 beneficiaries totaling $604,836 in drug costs, led by Humira(Cf) Pen (Adalimumab). DME data shows 317 claims. Open Payments data shows 172 records totaling $3,306. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $113,942 to $473,052. Similarly, Part D prescription costs have moved sharply higher in recent years, from $81,703 to $604,836. In contrast, DME billing represents a smaller volume and rose steadily, from $1,604 to $10,235.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	70	12,272	$113,942
2016	91	26,779	$256,924
2017	119	32,653	$424,575
2018	122	30,291	$413,478
2019	121	35,125	$443,029
2020	121	44,665	$447,196
2021	142	63,309	$586,386
2022	146	65,555	$472,336
2023	156	57,323	$462,886
2024	162	58,058	$473,052

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	58	431	$81,703
2016	52	427	$95,690
2017	72	463	$119,938
2018	103	740	$232,148
2019	107	814	$268,679
2020	109	824	$256,039
2021	125	887	$161,565
2022	119	815	$176,074
2023	155	1,062	$675,980
2024	162	1,117	$604,836

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	91	$71,347
2016	N/R	145	$124,535
2017	N/R	188	$93,892
2018	N/R	173	$88,094
2019	N/R	194	$96,261
2020	N/R	198	$115,650
2021	N/R	216	$127,262
2022	N/R	222	$116,044
2023	N/R	230	$117,997
2024	N/R	317	$193,223

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	62	89	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	107	214	$81
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	28	104	$44
96372	Injection of drug or substance under skin or into muscle	26	220	$10
J7050	Infusion, normal saline solution, 250 cc	33	227	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	25	700	$255,244
Orencia Clickject	Abatacept	18	504	$103,961
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	16	448	$42,286
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	1,140	$22,783
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	187	10,852	$5,724

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	73	$127,687
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	13	$28,982
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	13	$26,320
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	93	$6,421
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	11	$2,235

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	172	$3,306	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nancy Y. Olson, MD?

Tedicare shows public-source Medicare data for Nancy Y. Olson, MD (NPI 1265543466), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nancy Y. Olson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nancy Y. Olson, MD?

Nancy Y. Olson, MD is linked to ARCKC LLC (billing NPI 1861756041) in the available physician profile data.

Does Nancy Y. Olson, MD have Open Payments data?

Nancy Y. Olson, MD has 172 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.